研究文章
MMP9但不是EGFR,满足,ERCC1、P16, P-53与伴随的放疗反应,西妥昔单抗,每周顺铂在局部晚期头颈部癌症患者
表5
发病率在头部和颈部癌症患者切除修复基因型。外周血(PB)和肿瘤组织(TT)数据。
|
|
ERCC1 C8092A / |
|
|
|
|
|
|
|
|
|
|
|
|
|
CD3EAP Q504K |
ercc2 - 312 Asn / Asp |
赖氨酸/ Gln ercc2 - 751 |
xrcc1 - 399 Gln /参数 |
|
(CAG /亚美大陆煤层气有限公司) |
(AAC / GAC) |
(亚美大陆煤层气有限公司/ CAG) |
(CAG / CGG) |
|
| PB () |
C / C |
12 |
(46.2%) |
(G / G) |
Asp / Asp |
8 |
(30.8%) |
(C / C) |
Gln / Gln |
4 |
(15.4%) |
(G / G) |
参数/参数 |
8 |
(30.8%) |
|
A / C |
13 |
(50%) |
(A / G) |
Asn / Asp |
13 |
(50%) |
(A / C) |
赖氨酸/ Gln |
15 |
(57.7%) |
(A / G) |
Gln /参数 |
15 |
(57.7%) |
|
/一个 |
1 |
(3.8%) |
(/) |
Asn / Asn |
5 |
(19.2%) |
(/) |
赖氨酸、赖氨酸 |
7 |
(26.9%) |
(/) |
Gln / Gln |
3 |
(11.5%) |
| TT () |
C / C |
17 |
(51.5%) |
(G / G) |
Asp / Asp |
12 |
(38.7%) |
(C / C) |
Gln / Gln |
5 |
(16.1%) |
(G / G) |
参数/参数 |
12 |
(38.7%) |
|
A / C |
12 |
(36.4%) |
(A / G) |
Asn / Asp |
15 |
(48.4%) |
(A / C) |
赖氨酸/ Gln |
16 |
(51.6%) |
(A / G) |
Gln /参数 |
16 |
(51.6%) |
|
/一个 |
4 |
(12.1%) |
(/) |
Asn / Asn |
4 |
(12.9%) |
(/) |
赖氨酸、赖氨酸 |
10 |
(32.3%) |
(/) |
Gln / Gln |
3 |
(9.7%) |
|
Undet。 |
0 |
|
|
|
2 |
|
|
|
2 |
|
|
|
2 |
|
|
|
Undet。与实时PCR =待定。
|
